"Omics" and immunologic approaches to optimizing cure rates in HER2-positive breast carcinomas

Elda Tagliabue; Manuela Campiglio

doi:10.3389/fonc.2014.00334

"Omics" and immunologic approaches to optimizing cure rates in HER2-positive breast carcinomas

Fondazione IRCCS Istituto Nazionale dei Tumori

Research output: Contribution to journal › Editorial › peer-review

Original language	English
Article number	334
Journal	Frontiers in Oncology
Volume	4
Issue number	NOV
DOIs	https://doi.org/10.3389/fonc.2014.00334
Publication status	Published - 2014

Keywords

Breast cancer
HER2
Omics
Targeted therapy
Trastuzumab resistance

ASJC Scopus subject areas

Cancer Research
Oncology

Access to Document

10.3389/fonc.2014.00334

Cite this

@article{d20c980f94df456dadf21c92f2c42145,

title = "{"}Omics{"} and immunologic approaches to optimizing cure rates in HER2-positive breast carcinomas",

keywords = "Breast cancer, HER2, Omics, Targeted therapy, Trastuzumab resistance",

author = "Elda Tagliabue and Manuela Campiglio",

year = "2014",

doi = "10.3389/fonc.2014.00334",

language = "English",

volume = "4",

journal = "Frontiers in Oncology",

issn = "2234-943X",

publisher = "Frontiers Media S. A.",

number = "NOV",

}

TY - JOUR

T1 - "Omics" and immunologic approaches to optimizing cure rates in HER2-positive breast carcinomas

AU - Tagliabue, Elda

AU - Campiglio, Manuela

PY - 2014

Y1 - 2014

KW - Breast cancer

KW - HER2

KW - Omics

KW - Targeted therapy

KW - Trastuzumab resistance

UR - http://www.scopus.com/inward/record.url?scp=84987932389&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84987932389&partnerID=8YFLogxK

U2 - 10.3389/fonc.2014.00334

DO - 10.3389/fonc.2014.00334

M3 - Editorial

AN - SCOPUS:84987932389

SN - 2234-943X

VL - 4

JO - Frontiers in Oncology

JF - Frontiers in Oncology

IS - NOV

M1 - 334

ER -

"Omics" and immunologic approaches to optimizing cure rates in HER2-positive breast carcinomas

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this